The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Open accessAbstract
BACKGROUND: Patients with diabetes are at higher risk for death and cardiovascular outcomes than the general population. We investigated whether the excess risk of death and cardiovascular events among patients with type 2 diabetes could be reduced or eliminated. METHODS: In a cohort study, we included 271,174 patients with type 2 diabetes who were registered in the Swedish National Diabetes Register and matched them with 1,355,870 controls on the basis of age, sex, and county. We assessed patients with diabetes according to age categories and according to the presence of five risk factors (elevated glycated hemoglobin level, elevated low-density lipoprotein cholesterol level, albuminuria, smoking, and elevated blood pressure). Cox regression was used to study the excess risk of outcomes (death, acute myocardial infarction, stroke, and hospitalization for heart failure) associated with smoking and the number of variables outside target ranges. We also examined the relationship between various risk factors and cardiovascular outcomes. RESULTS: The median follow-up among all the study participants was 5.7 years, during which 175,345 deaths occurred. Among patients with type 2 diabetes, the excess risk of outcomes decreased stepwise for each risk-factor variable within the target range. Among patients with diabetes who had all five variables within target ranges, the hazard ratio for death from any cause, as compared with controls, was 1.06 (95% confidence interval [CI], 1.00 to 1.12), the hazard ratio for acute myocardial infarction was 0.84 (95% CI, 0.75 to 0.93), and the hazard ratio for stroke was 0.95 (95% CI, 0.84 to 1.07). The risk of hospitalization for heart failure was consistently higher among patients with diabetes than among controls (hazard ratio, 1.45; 95% CI, 1.34 to 1.57). In patients with type 2 diabetes, a glycated hemoglobin level outside the target range was the strongest predictor of stroke and acute myocardial infarction; smoking was the strongest predictor of death. CONCLUSIONS: Patients with type 2 diabetes who had five risk-factor variables within the target ranges appeared to have little or no excess risk of death, myocardial infarction, or stroke, as compared with the general population. (Funded by the Swedish Association of Local Authorities and Regions and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“when all major cardiovascular risk factors are treated to within the target ranges, people with type 2 diabetes have risk of death, MI, or stroke similar to that of the general population (6).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Among persons with type 2 diabetes (T2D), cardiovascular risk and mortality are dependent on the number of uncontrolled risk factors.”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the evidence from prospective intervention studies to support comprehensive ASCVD risk factor reduction, a large cohort study confirmed no or only marginally increased mortality, MI, and stroke risk compared with the general population when all major cardiovascular risk factors are managed to goal levels in people with type 2 diabetes (6).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Hypertriglyceridemia is indirectly linked with changes in HDL-C and LDL-C composition that are conducive to accelerated atherogenesis.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [313]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In persons with fasting triglycerides of 200 to 499 mg/dL, despite tight adherence to a healthy diet (to include reduced intake of simple carbohydrates and avoidance of fruit juices and alcohol) and optimized glycemia control, prescribe statin therapy to the maximum tolerated dose to achieve goals for non-HDL-C or apo B, since all apo B–containing particles are potentially atherogenic.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [313]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To date, aside from icosapent ethyl, fish oil therapy has not been shown to prevent CV adverse events.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [313]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“No RCT has yet been reported to investigate the benefit of reducing severe (>500 mg/dL) or moderate (>200 mg/dL) hypertriglyceridemia to prevent CVD.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [313]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Despite these newer therapies, the risk of kidney failure remains high, particularly in those whose risk factors are insufficiently controlled.6,7”
From The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“In patients with advanced disease, e.g.T2DM and established microalbuminuria, an intensive, target-driven, multifactorial therapy (Steno-2 study; targets: HbA1c <6.5%, total cholesterol <4.5 mmol/L [175 mg/dL], and BP <130/80 mmHg) resulted in 50% fewer microvascular and macrovascular events after 7.8 years of follow-up.361”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [361]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Mortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389
Self-citation
Cited by
Sorted by citations
Items 601–700 of 999
Li, X., Shi, Y., Wei, D., Ni, W., Zhu, N., & Yan, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1283626 · Cited by 9
Buraczyńska, M., Wrzos, S., & Załuska, W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12226990 · Cited by 9
Zeng, F., Zhou, P., Wang, M., Xie, L., Huang, X., Wang, Y., Huang, J., Shao, X., Yang, Y., Liu, W., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111014 · Cited by 10
Li, J., Li, J., Yu, Y., Sun, Y. B., Yu, B., Shen, W., Cai, L., Wang, N., Wang, B., & Lu, Y. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100342 · Cited by 10
Boc, V., Mijovski, M. B., Perme, M. P., & Blinc, A. (2018) · VASA · doi:10.1024/0301-1526/a000766 · Cited by 9
Evaluación y manejo del riesgo cardiovascular residual en el paciente con diabetes
Orna, J. A. G., Toro, J. J. O., & Miranda, C. M. P. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.05.004 · Cited by 9
Type 2 diabetes: Why should diabetologists and cardiologists work more closely together?
Valensi, P. E., Picard, S., & Pathak, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.07.007 · Cited by 9
Palazón‐Bru, A., Ferri-Rufete, D., Mares‐García, E., Durazo-Arvizú, R., Divisón, J. A., Herencia, J. A. C., Artigao-Rodenas, L. M., Rueda, M. S., Escribano, F. M., Ponce-García, I., et al. (2020) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000637 · Cited by 9
Eliasson, B., Ekelund, J., Miftaraj, M., Ranthe, M. F., MÅRDBY, A.-C. M., Fernandes, J. D. D. R., & Svensson, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00872-4 · Cited by 10
Self-citationThe future of Diabetic Kidney Disease management: reducing the unmet need
de Zeeuw, D. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00820-2 · Cited by 9
Sex differences in the prevalence of obesity in 800,000 Chinese adults with type 2 diabetes
Lv, F., Cai, X., Lin, C., Hong, T., Zhang, X., Wang, Z., Xing, H., Zong, G., Lu, J., Guo, X., et al. (2021) · Endocrine Connections · doi:10.1530/ec-20-0547 · Cited by 9
Trevisan, C., Capodaglio, G., Ferroni, E., Fedeli, U., Noale, M., Baggio, G., Manzato, E., Maggi, S., Corti, M. C., & Sergi, G. (2021) · European Journal of Ageing · doi:10.1007/s10433-021-00620-y · Cited by 9
Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program
Ferrannini, G., Rosenthal, N. R., Hansen, M. K., & Ferrannini, E. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01558-w · Cited by 9
Olomu, A. B., Kelly‐Blake, K., Hart-Davidson, W., Gardiner, J. C., Luo, Z., Heisler, M., & Holmes-Rovner, M. M. (2022) · Trials · doi:10.1186/s13063-022-06581-6 · Cited by 11
Abdel‐Rahman, N., Calderon‐Margalit, R., Cohen, A. D., Elran, E., Golan‐Cohen, A., Krieger, M., Paltiel, O., Valinsky, L. J., Ben‐Yehuda, A., & Manor, O. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025603 · Cited by 9
Zibaeenezhad, M. J., Sayadi, M., Mohammadi, S. S., Khorshidi, S., Hadiyan, E., Rasouli, N., Akhormeh, A. K., & Razeghian‐Jahromi, I. (2023) · The Journal of Tehran University Heart Center · doi:10.18502/jthc.v17i4.11609 · Cited by 10
Winell, K., Pietilä, A., & Salomaa, V. V. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1602734 · Cited by 9
Lawson, C. A., Zaccardi, F., McCann, G. P., Davies, M. J., Kadam, U. T., & Khunti, K. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.16447 · Cited by 9
Wang, J., Ke, J.-F., Zhang, Z.-H., Lu, J., & Li, L. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00824-x · Cited by 9
Nilsson, K., Andersson, E., Persson, S., Karlsdotter, K., Skogsberg, J., Gustavsson, S., JENDLE, J. H., & Carlsson, K. S. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14921 · Cited by 7
Körei, A. E., Békeffy, M. Z., Menyhárt, A., Osgyán, K., Istenes, I., Horváth, V. J., & Kempler, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1302013 · Cited by 9
Hyperglycemia-induced hemichorea-hemiballismus syndrome – a systematic review
Hoffmeister, M. C., Bonavides, P. S. G., Wiercinski, V. M., Baggio, V. A., Borges, R. D. P., Xavier, G. F., Maraschin, C. K., & Schaan, B. D. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2022-0413 · Cited by 8
Mohammedi, K., Fauchier, L., Quignot, N., Khachatryan, A., Banon, T., Kapnang, R., Kikuchi, K., Ren, H., Massien, C., Vigié, L., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02257-4 · Cited by 8
Diabetes and Heart Failure: A Literature Review, Reflection and Outlook
Li, X., Zhou, X., & Gao, L. (2024) · Biomedicines · doi:10.3390/biomedicines12071572 · Cited by 10
van der Stouwe, J. G., Godly, K., Kraler, S. C., Godly, J., Matter, C. M., Wenzl, F. A., von Eckardstein, A., Räber, L., Mach, F., Obeid, S. N., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14314 · Cited by 9
Neves, J. S., Baptista, R., de Pape, E. A., Pereira, M. R., Paulos, R., Santos, J. A., Gavina, C., & de Castro, J. J. (2024) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2024.07.010 · Cited by 11
Pencina, K. M., Thanassoulis, G., Pencina, M. J., Toth, P. P., & Sniderman, A. D. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02525-3 · Cited by 9
Moon, S.-J., Kim, M.-S., Kim, Y. T., Lee, H., Lee, Y., Lee, S.-J., Chung, E.-S., & Park, C.-Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02747-z · Cited by 8
Yan, D., Li, X., Wang, Y., & Cai, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1593068 · Cited by 8
Risk Factor Control in U.S. Adults With Cardiovascular-Kidney-Metabolic Multimorbidity, 1999-2020
Ostrominski, J. W., Hirsch, J. S., Miao, B., Clark, B. J., Donato, B. M. K., Woolley, J. J., Parrinello, C. M., O’Connell, T., & Vaduganathan, M. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.05.052 · Cited by 8
Chung, G. S., Si, Y., Aryal, K., Bahendeka, S., Banegas, J. R., Bärnighausen, T., Barreto, M., Basit, A., Bello-Chavolla, O. Y., Bovet, P., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00393-6 · Cited by 8
Moissl, A. P., Delgado, G. E., Krämer, B. K., Siekmeier, R., Duerschmied, D., März, W., & Kleber, M. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010241 · Cited by 10
Šedová, P., Vrablı́k, M., Kala, P., Ošťádal, P., Tichopád, A., Tomek, A., Mikulík, R., Donin, G., Littnerová, S., Kent, J. A., et al. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag002 · Cited by 8
Zhang, X., Chen, X., Tang, Y., Guan, X.-X., Deng, J., & Fan, J. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14130 · Cited by 9
Cardiovascular risk factors in the elderly: a 10-year follow-up survival analysis
de Sousa, T. V., Cavalcante, Á. M. R. Z., Lima, N. X., Souza, J. S., Sousa, A. L. L., Brasil, V. V., VIEIRA, F. V. M., Guimarães, J. V., de Matos, M. A., Silveira, É. A., et al. (2022) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvac040 · Cited by 8
Katsuyama, H., Hakoshima, M., Adachi, H., Masui, Y., Sako, A., Inokuma, S., & Yanai, H. (2022) · Cardiology Research · doi:10.14740/cr1371 · Cited by 8
Risk factors of acute cerebral infarction in patients with primary hypertension
Zheng, D., Li, X., & Fu, Y. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03206-4 · Cited by 8
Majić, A., Arsenović, D., & Čvokić, D. D. (2023) · Healthcare · doi:10.3390/healthcare11040483 · Cited by 11
Singeisen, H., Renström, F., Laimer, M. W., Lehmann, R., Bilz, S., & Brändle, M. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad178 · Cited by 8
Cardioprotective antihyperglycemic drugs ameliorate endoplasmic reticulum stress
Mooradian, A. D., & Haas, M. J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00470.2023 · Cited by 8
Nadarajah, R., Ludman, P., Laroche, C., Appelman, Y., Brugaletta, S., Budaj, A., Bueno, H., Huber, K., Kunadian, V., Leonardi, S., et al. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae002 · Cited by 8
Choi, J., Lee, S., Choi, E., Lee, K., Ahn, H., Kwon, S., Han, K., Oh, S., & Lip, G. Y. H. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02194-2 · Cited by 10
Wang, L., Zhang, W., Dai, J., Deng, Q., Yan, Y., & Liu, Q. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14196 · Cited by 9
Zhang, J. Y., He, M., Gao, G., & Sun, T. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2358741 · Cited by 9
Segar, M. W., Usman, M., Patel, K. V., Khan, M. S., Butler, J., Manjunath, L., Lam, C. S. P., Verma, S., Willett, D. L., Kao, D. P., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3443 · Cited by 8
Lee, H., Fernandes, M., Lee, J., Merino, J., & Kwak, S. H. (2025) · Diabetologia · doi:10.1007/s00125-025-06403-9 · Cited by 9
Milà, L., Barrabés, J. A., Lidón, R. M., Sambola, A., Bañeras, J., Oristrell, G., Rafecas, A., & David Garcia-dorado, A. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.06.014 · Cited by 8
Second revolution in cardiovascular prevention
Chiang, C., Wang, K.-L., Cheng, H., Sung, S., & Chao, T. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000276 · Cited by 8
Höbaus, C., Herz, C. T., Wrba, T., Koppensteiner, R., & Schernthaner, G.-H. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120914845 · Cited by 10
Napoli, R., Formoso, G., Piro, S., Targher, G., Consoli, A., & Purrello, F. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.012 · Cited by 9
Pujante, P., Torre, E. L. M., Morales-Sánchez, P., Escobedo, R. R., Barreiro, S. C., Rojo‐Martínez, G., & Delgado, E. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2020.12.040 · Cited by 8
Pan‐risk factor for a comprehensive cardiovascular health management
Zheng, R., Xu, Y., Li, M., Lu, J., Xu, M., Wang, T., Zhao, Z., Wang, S., Lin, H., Zhang, X., et al. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13258 · Cited by 7
Delgado, E., Jódar, E., Mezquita‐Raya, P., & Moreno, Ó. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01278-0 · Cited by 8
Platelet Reactivity and Cardiovascular Mortality Risk in the LURIC Study
Berger, M., Dressel, A., Kleber, M. E., März, W., Hellstern, P., Marx, N., & Schütt, K. S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051913 · Cited by 8
Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus
Godoy, L. C., Tavares, C. A. M., & Farkouh, M. E. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.08.002 · Cited by 9
Patient-perceived service needs and health care utilization in people with type 2 diabetes
Ni, Y., Liu, S., Li, J., Li, S., & Dong, T. (2020) · Medicine · doi:10.1097/md.0000000000020322 · Cited by 8
Rubinowicz-Zasada, M., Kucio, E. B., Polak, A., Šťastný, P., Wierzbicki, K., Król, P., & Kucio, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073433 · Cited by 8
Smoking and Other Risk Factors in Type 2 Diabetes
Anker, M. S., Kalantar‐Zadeh, K., & Doehner, W. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1812842 · Cited by 8
Personalizing Risk Assessment in Diabetes Mellitus and Metabolic Syndrome
Mitchell, J. D. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.11.002 · Cited by 8
Aydin-Ghormoz, H., Adeyeye, T. E., Muscatiello, N. A., Nayak, S. G., Savadatti, S. S., & Insaf, T. Z. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416411 · Cited by 8
Yokoyama, H., Araki, S., Kawai, K., Yamazaki, K., Tomonaga, O., Maeda, H., Ohtaki, M., Obata, H., Sone, H., Kabata, D., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110674 · Cited by 7
Verma, S., Kosmopoulos, A., Bhatt, D. L., FITCHETT, D. H., Ofstad, A. P., Wanner, C., Mattheus, M., Zinman, B., Lawler, P. R., & Leiter, L. A. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100510 · Cited by 7
Mesenchymal Stem Cell-Derived Exosomes: A Novel Approach to Diabetes-Associated Cognitive Impairment
Ran, Q., He, T., Lin, J. X., Wang, H., Wang, B., Chen, Z., Song, D. F., & Gong, C. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s429532 · Cited by 7
Cherney, D. Z. I., Drzewiecka, A., Folkerts, K., Lévy, P., Millier, A., Stephen Morris, A., Pochopień, M., Roy‐Chaudhury, P., Sullivan, S. D., & Mernagh, P. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2451526 · Cited by 7
Pingping, W., Hu, C., Li, Q., Wu, K., Xianghua, C., Fu, X., Peng, Y., & Chen, C. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141949 · Cited by 7
Kou, M., Li, X., Ma, H., Wang, X., Heianza, Y., Manson, J. E., & Li, X. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01225-w · Cited by 7
Pharmacologic Therapies for Type 2 Diabetes
Kuo, B., & Li, J. H. (2025) · NEJM Evidence · doi:10.1056/evidra2400265 · Cited by 8
Wijkman, M. O., Claggett, B. L., Díaz, R., Gerstein, H. C., Køber, L., Lewis, E. F., Maggioni, A. P., Wolsk, E., Aguilar, D. A., Bentley–Lewis, R., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01150-0 · Cited by 6
Changes in diabetes mortality rate in Costa Rica 2007–2017
Jiménez-Montero, J. G., & Villegas-Barakat, M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108749 · Cited by 9
Inglin, L., Lavikainen, P., Jalkanen, K., & Laatikainen, T. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-02077-6 · Cited by 7
Yamaji, T., Harada, T., Hashimoto, Y., Takaeko, Y., Kajikawa, M., Han, Y., Maruhashi, T., Kishimoto, S., Hashimoto, H., Kihara, Y., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045415 · Cited by 6
Nagori, A., Segar, M. W., Keshvani, N., Patel, L., Patel, K. V., Chandra, A., Willett, D. L., & Pandey, A. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231212219 · Cited by 7
Yoo, J. E., Jeong, S., Lee, K., Lee, H., Yoon, J. W., Han, K., & Shin, D. W. (2024) · JMIR Public Health and Surveillance · doi:10.2196/46450 · Cited by 6
Cai, X., Xu, X., He, G., Jiang, X., & Wu, L. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09712-3 · Cited by 9
Sakamoto, T., Miyamoto, H., Hashizume, J., Akamatsu, H., Akagi, T., Kodama, Y., Hamano, H., Zamami, Y., & Ohyama, K. (2024) · Clinical Drug Investigation · doi:10.1007/s40261-024-01394-8 · Cited by 7
Current Smoking: An Independent Predictor of Elevated A1C in Persons With Type 2 Diabetes
DiNardo, M. M., Sereika, S. M., Korytkowski, M. T., Baniak, L. M., Weinzierl, V., Hoenstine, A. L., & Chasens, E. R. (2019) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721719829068 · Cited by 7
Кобалава, Ж. Д., Medovchshikov, V., Yeshniyazov, N., & Хасанова, Э. Р. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-11-98-111 · Cited by 7
Cross talk between exosomes and pancreatic β-cells in diabetes
Wu, Y. Z., Huang, Q., & Bu, S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1760303 · Cited by 7
Bersch-Ferreira, Â. C., Weber, B., da Silva, J. G. S. T., Pagano, R., Figueiró, M. F., da Silva, L. R., Mota, L. G. D. S., Suzumura, É. A., Torreglosa, C. R., Lara, E. D. S., et al. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200810131055 · Cited by 8
Vaccaro, O., Vitale, M., Costanzo, S., Masulli, M., Riccardi, G., Curtis, A. D., Donati, M. B., Rivellese, A. A., de Gaetano, G., & Iacoviello, L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108370 · Cited by 7
Recomendaciones para el manejo del riesgo cardiorrenal en el paciente con diabetes mellitus tipo 2
Castillo, G. A., Aroca, G., Buelvas, J., Buitrago, A. F., Carballo-Zárate, V., Cárdenas, J. M., Gómez, E. A., Fériz, K., Lopera, J. M., Enrique Melgarejo, R., et al. (2020) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2020.07.005 · Cited by 7
Hjortbak, M. V., Groennebaek, T., Jespersen, N. R., Lassen, T. R., Seefeldt, J. M., Tonnesen, P. T., Jensen, R. V., Koch, L. G., Britton, S. L., Pedersen, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240866 · Cited by 7
Zabala, A., Gottsäter, A., Lind, M., Svensson, A., Eliasson, B., Bertilsson, R., Ekelund, J., Nyström, T., & Jonsson, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01282-x · Cited by 7
Self-citationPrevalence and incidence of type 2 diabetes in Iceland 2005-2018
Þórsson, B., Gudmundsson, E. F., Sigurðsson, G., Aspelund, T., & Gudnason, V. G. (2021) · Læknablaðið · doi:10.17992/lbl.2021.05.634 · Cited by 10
Pagidipati, N. J., & DEEDWANIA, P. C. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.04.024 · Cited by 7
Ohde, S., Moriwaki, K., & Takahashi, O. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00771-0 · Cited by 7
Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test
Ferrannini, G., Bacquer, D. D., Gyberg, V., Backer, G. D., Kotseva, K., Mellbin, L., Risebrink, R., Tuomilehto, J. O., Wood, D., & Rydén, L. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109156 · Cited by 7
Glucose-derived posttranslational modification in cardiovascular disease
Lehrke, M., Moellmann, J., Kahles, F., & Marx, N. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101084 · Cited by 7
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization
Yamaji, K., Shiomi, H., Morimoto, T., Matsumura‐Nakano, Y., Ehara, N., Sakamoto, H., Takeji, Y., Yoshikawa, Y., Yamamoto, K., Kato, E. T., et al. (2022) · JACC Asia · doi:10.1016/j.jacasi.2021.12.012 · Cited by 7
Niwaha, A. J., Rodgers, L. R., Carr, A. L. J., Balungi, P., Mwebaze, R. M., Hattersley, A. T., Shields, B. M., Nyirenda, M., & Jones, A. G. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002714 · Cited by 7
Levels and correlates of risk factor control in diabetes mellitus –ELSA-Brasil
Chwal, B. C., dos Reis, R. C. P., Schmidt, M. I., Duncan, B. B., Barreto, S. M., & Griep, R. H. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00961-3 · Cited by 8
Fu, B., Yu, Y., Cheng, S., Huang, H., Long, T., Yang, J., Gu, M., Cai, C., Chen, X., Niu, H., et al. (2023) · The Journal of Nutrition, Health & Aging · doi:10.1007/s12603-023-2042-6 · Cited by 8
Jernberg, T., Lindholm, D. P., Hasvold, L. P., Svennblad, B., Bodegård, J., Andersson, K., Thuresson, M., Erlinge, D., & Janzon, M. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027199 · Cited by 7
Jia, A., Zeng, W., Yu, L., Zeng, H., Lü, Z., & Song, Y. (2019) · SAGE Open Medicine · doi:10.1177/2050312119871786 · Cited by 7
A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart Failure
Sano, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17042 · Cited by 7
Rados, D. R. V., Viecceli, C., Pinto, L. C. F., Gerchman, F., Leitão, C. B., & Gross, J. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-69738-w · Cited by 6
Recent dyslipidemia guidelines for patients with diabetes mellitus
Rhee, E. (2020) · Precision and Future Medicine · doi:10.23838/pfm.2020.00100 · Cited by 7
Lamidi, M., Wikström, K., Inglin, L., Rautiainen, P., Tirkkonen, H., & Laatikainen, T. K. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01324-5 · Cited by 7
Andersson, T., Pikkemaat, M., Schiöler, L., Hjerpe, P., Carlsson, A. C., Wändell, P. E., Manhem, K., Kahan, T., & Boström, K. B. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002744 · Cited by 7
Марущак, М. І. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.03.20 · Cited by 8
Metadata
- Authors
- Rawshani, A., Rawshani, A., Franzén, S., Sattar, N., Eliasson, B., Svensson, A.-M., Zethelius, B., Miftaraj, M., McGuire, D. K., Rosengren, A., & Gudbjörnsdottir, S.
- Affiliations
- Uppsala University (SE)
- From the Department of Molecular and Clinical Medicine, Institute of Medicine (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren, S.G.), and the Health Metrics Unit, Sahlgrenska Academy (S.F.), University of Gothenburg, and the Swedish National Diabetes Register, Center of Registers in Region (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.), Gothenburg, and the Department of Public Health and Caring Sciences–Geriatrics, Uppsala University, and the Swedish Medical Products Agency,...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-08-16
- Volume
- 379
- Issue
- 7
- Pages
- 633-644
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2887185538
- Cited by
- 1,475
- References
- 22
- Citations by year
- 2026: 158 · 2025: 172 · 2024: 178 · 2023: 175 · 2022: 197 · 2021: 219 · 2020: 210 · 2019: 141 · 2018: 20
- FWCI
- 116.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, cardiovascular risk factors, mortality, acute myocardial infarction, stroke, heart failure hospitalization, HbA1c, LDL cholesterol, albuminuria, smoking, blood pressure, Swedish National Diabetes Register, matched cohort comparison
- MeSH terms
- Adult, Albuminuria, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypercholesterolemia, Hypertension, Male, Middle Aged, Myocardial Infarction, Risk Factors, Smoking, Sweden, Cohort Studies, Body Mass Index, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
